InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B & s708 Notice 3 Jan 2017 8:22AM $0.058 $0.230 risen by 296.55%
- PharmAust raises a further $1.56m 30 Dec 2016 11:46AM $0.058 $0.230 risen by 296.55%
- Change of Director's Interest Notice x 4 13 Dec 2016 3:46PM $0.058 $0.230 risen by 296.55%
- Completion of Rights Issue & Notice of Shortfall 8 Dec 2016 11:34AM $0.048 $0.230 risen by 379.17%
- No Extension of Closing Date in Rights Issue 6 Dec 2016 8:27AM $0.050 $0.230 risen by 360%
- Rights Issue - Extension of Closing Date 5 Dec 2016 2:38PM $0.050 $0.230 risen by 360%
- Phase II Strategy Update 21 Nov 2016 8:29AM $0.050 $0.230 risen by 360%
- Results of Annual General Meeting 11 Nov 2016 11:58AM $0.055 $0.230 risen by 318.18%
- PharmAust AGM Presentation 11 Nov 2016 9:49AM $0.051 $0.230 risen by 350.98%
- Appendix 3B 8 Nov 2016 8:57AM $0.070 $0.230 risen by 228.57%
- Letter to Optionholders 8 Nov 2016 8:31AM $0.070 $0.230 risen by 228.57%
- Prospectus 8 Nov 2016 8:29AM $0.070 $0.230 risen by 228.57%
- Appendix 4C - Quarterly Report & Company Update 31 Oct 2016 8:22AM $0.076 $0.230 risen by 202.63%
- Second canine receives treatment in trial 14 Oct 2016 8:27AM $0.081 $0.230 risen by 183.95%
- Notice of Annual General Meeting/Proxy Form 11 Oct 2016 2:25PM $0.080 $0.230 risen by 187.50%
- Phase II Canine Trial begins at University of Cambridge 19 Sep 2016 8:26AM $0.082 $0.230 risen by 180.49%
- Epichem achieves ISO 9001 2015 certification 16 Sep 2016 8:25AM $0.082 $0.230 risen by 180.49%
- MPL capsules shipped to centres in NSW & Qld for Phase II 13 Sep 2016 8:39AM $0.082 $0.230 risen by 180.49%
- Appendix 4G & Corporate Governance Statement 31 Aug 2016 4:59PM $0.088 $0.230 risen by 161.36%
- Appendix 4E & Full Year Statutory Accounts 2016 31 Aug 2016 4:55PM $0.088 $0.230 risen by 161.36%
- PharmAust Investor Presentation - August 2016 29 Aug 2016 8:18AM $0.089 $0.230 risen by 158.43%
- Further Canine Trials to be Initiated in Australia 10 Aug 2016 9:32AM $0.090 $0.230 risen by 155.56%
- IP exchange with UNSW consolidates MPL patent position 3 Aug 2016 8:23AM $0.087 $0.230 risen by 164.37%
- Appendix 4C Quarterly & Brief Company Update - June 2016 29 Jul 2016 8:19AM $0.095 $0.230 risen by 142.11%
- Investor Call 19 Jul 2016 9:58AM $0.086 $0.230 risen by 167.44%

526 - 550 of 796 results

Page 22 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.